- RF Generators
- Reusable Products
- Probes
- Electrodes
- Disposable Products
- Cannulas
- Needles
Radiofrequency Ablation Devices Market size was valued at USD 3.5 billion in 2022 and is poised to grow at a CAGR of 10.3% from 2023-2029. Radiofrequency ablation (RFA), also known as fulguration, is a medical treatment in which heat produced by medium frequency alternating current (in the 350–500 kHz range) is used to ablate a portion of the heart's electrical conduction system, a tumour, or other defective tissue. RFA is typically performed under twilight anaesthesia or local anaesthetics in an outpatient environment. It is known as radiofrequency catheter ablation when administered via the catheter. Radiofrequency current has two major advantages over low-frequency AC or DC pulses: it is very specific in treating the desired tissue with minimal collateral damage, and it does not directly stimulate the heart muscle or nerves, so it can often be used without the need for general anaesthesia. As a result, it is becoming more and more popular as an alternative for eligible patients who do not want to undergo surgery.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Increase in the prevalence of chronic diseases such as cancer is the key factor attributing the growth of the radiofrequency ablation devices market. Rising geriatric population along with health issues is anticipating the growth of the market. Increase in the adoption minimal invasive procedures by the patient population is enhancing the growth of the market. The increase in the technological advancements are providing an opportunity for the growth of the growth of the market However, the high cost of the treatment is hindering the growth of the market. The availability of alternate procedures is hampering the growth of the radiofrequency ablation devices market.
The radiofrequency ablation devices market size was valued at USD 3.5 billion in 2022
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
The radiofrequency ablation devices market key players are Smith & Nephew plc (U.K.), Olympus Corporation (Japan), Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), CONMED Corporation (U.S.), AngioDynamics, Inc. (U.S.)
1. Executive Summary |
2. Global Radiofrequency Ablation Devices Market Introduction |
2.1. Global Radiofrequency Ablation Devices Market - Taxonomy |
2.2. Global Radiofrequency Ablation Devices Market - Definitions |
2.2.1. By Product Type |
2.2.2. By Application |
2.2.3. By Distribution Channel |
2.2.4. By Region |
3. Global Radiofrequency Ablation Devices Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Key Developments |
4. Global Radiofrequency Ablation Devices Market By Product Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
4.1. RF Generators |
4.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.1.3. Market Opportunity Analysis |
4.2. Reusable Products |
4.2.1. Probes |
4.2.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.2.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.2.1.3. Market Opportunity Analysis |
4.2.2. Electrodes |
4.2.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.2.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.2.2.3. Market Opportunity Analysis |
4.3. Disposable Products |
4.3.1. Cannulas |
4.3.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.3.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.3.1.3. Market Opportunity Analysis |
4.3.2. Needles |
4.3.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.3.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3.2.3. Market Opportunity Analysis |
5. Global Radiofrequency Ablation Devices Market By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
5.1. Pain management |
5 1 1 Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Gynecology |
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Hypertension |
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Cosmetology |
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Surgical Oncology |
5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Cardiology & Cardiac Rhythm Management |
5.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
6. Global Radiofrequency Ablation Devices Market By Distribution Channel, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
6.1. Hospitals |
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
7. Global Radiofrequency Ablation Devices Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia Pacific |
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Latin America |
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. MEA |
7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
7.6. Global Radiofrequency Ablation Devices Market - Opportunity Analysis Index, By Application, Product Type, Distribution Channel, , , , , and Region, 2023-2029 |
8. North America Radiofrequency Ablation Devices Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
8.1. Product Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1. RF Generators |
8.1.2. Reusable Products |
8.1.2.1. Probes |
8.1.2.2. Electrodes |
8.1.3. Disposable Products |
8.1.3.1. Cannulas |
8.1.3.2. Needles |
8.2. Application Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1. Pain management |
8.2.2. Gynecology |
8.2.3. Hypertension |
8.2.4. Cosmetology |
8.2.5. Surgical Oncology |
8.2.6. Cardiology & Cardiac Rhythm Management |
8.3. Distribution Channel Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.3.1. Hospitals |
8.4. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.4.1. USA |
8.4.2. Canada |
9. Europe Radiofrequency Ablation Devices Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
9.1. Product Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1. RF Generators |
9.1.2. Reusable Products |
9.1.2.1. Probes |
9.1.2.2. Electrodes |
9.1.3. Disposable Products |
9.1.3.1. Cannulas |
9.1.3.2. Needles |
9.2. Application Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1. Pain management |
9.2.2. Gynecology |
9.2.3. Hypertension |
9.2.4. Cosmetology |
9.2.5. Surgical Oncology |
9.2.6. Cardiology & Cardiac Rhythm Management |
9.3. Distribution Channel Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1. Hospitals |
9.4. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1. Germany |
9.4.2. France |
9.4.3. Italy |
9.4.4. Spain |
9.4.5. UK |
9.4.6. Rest of Europe |
10. Asia Pacific Radiofrequency Ablation Devices Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
10.1. Product Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1. RF Generators |
10.1.2. Reusable Products |
10.1.2.1. Probes |
10.1.2.2. Electrodes |
10.1.3. Disposable Products |
10.1.3.1. Cannulas |
10.1.3.2. Needles |
10.2. Application Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1. Pain management |
10.2.2. Gynecology |
10.2.3. Hypertension |
10.2.4. Cosmetology |
10.2.5. Surgical Oncology |
10.2.6. Cardiology & Cardiac Rhythm Management |
10.3. Distribution Channel Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1. Hospitals |
10.4. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1. China |
10.4.2. Japan |
10.4.3. South Korea |
10.4.4. India |
10.4.5. Rest of APAC |
11. Latin America Radiofrequency Ablation Devices Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
11.1. Product Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1. RF Generators |
11.1.2. Reusable Products |
11.1.2.1. Probes |
11.1.2.2. Electrodes |
11.1.3. Disposable Products |
11.1.3.1. Cannulas |
11.1.3.2. Needles |
11.2. Application Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1. Pain management |
11.2.2. Gynecology |
11.2.3. Hypertension |
11.2.4. Cosmetology |
11.2.5. Surgical Oncology |
11.2.6. Cardiology & Cardiac Rhythm Management |
11.3. Distribution Channel Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1. Hospitals |
11.4. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1. Brazil |
11.4.2. Mexico |
11.4.3. Argentina |
11.4.4. Rest of Latin America |
12. MEA Radiofrequency Ablation Devices Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
12.1. Product Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1. RF Generators |
12.1.2. Reusable Products |
12.1.2.1. Probes |
12.1.2.2. Electrodes |
12.1.3. Disposable Products |
12.1.3.1. Cannulas |
12.1.3.2. Needles |
12.2. Application Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1. Pain management |
12.2.2. Gynecology |
12.2.3. Hypertension |
12.2.4. Cosmetology |
12.2.5. Surgical Oncology |
12.2.6. Cardiology & Cardiac Rhythm Management |
12.3. Distribution Channel Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1. Hospitals |
12.4. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1. GCC Countries |
12.4.2. South Africa |
12.4.3. Rest of MEA |
13. Competition Landscape |
13.1. Strategic Dashboard of Top Market Players |
13.2. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis) |
13.2.1. Smith & Nephew plc (U.K.) |
13.2.2. Olympus Corporation (Japan) |
13.2.3. Jude Medical, Inc. (U.S.) |
13.2.4. Boston Scientific Corporation (U.S.) |
13.2.5. CONMED Corporation (U.S.) |
13.2.6. AngioDynamics, Inc. (U.S.) |
13.2.7. AtriCure, Inc. (U.S.) |
13.2.8. Medtronic, Inc. (U.S.) |
13.2.9. Biosense Webster, Inc. (U.S.) |
14. Research Methodology |
15. Key Assumptions and Acronyms |